IMPACT OF ANTIFIBROTIC USE ON HEALTHCARE RESOURCE USE AND COST IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) IN A COMMERCIALLY INSURED PATIENT POPULATION

被引：1
|
作者：
Corral, Mitra
Deyoung, Kathryn
Kong, Amanda
机构：
来源：
CHEST | 2019年 / 156卷 / 04期
关键词：
D O I：
10.1016/j.chest.2019.08.1038
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1137A / 1137A
页数：1
相关论文
共 50 条
  • [21] BURDEN OF IDIOPATHIC PULMONARY FIBROSIS (IPF) ON QUALITY OF LIFE (QOL), WORK PRODUCTIVITY AND HEALTHCARE USE
    Coteur, G.
    Inoue, Y.
    Cottin, V
    Small, M.
    Siddall, J.
    Langley, J.
    Bonella, F.
    Lancaster, L.
    VALUE IN HEALTH, 2020, 23 : S732 - S732
  • [22] Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Cottin, Vincent
    Spagnolo, Paolo
    Bonniaud, Philippe
    Dalond, Faustine
    Nolind, Maeva
    Kirchgassler, Klaus-Uwe
    Van Ganse, Eric
    Belhassen, Manon
    RESPIRATORY MEDICINE AND RESEARCH, 2023, 83
  • [23] Burden of idiopathic pulmonary fibrosis (IPF) on quality of life (QoL), work productivity, and healthcare use
    Inoue, Yoshikazu
    Cottin, Vincent
    Small, Mark
    Siddall, James
    Langley, Jonathan
    Bonella, Francesco
    Lancaster, Lisa
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [24] Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria
    Broder, Michael S.
    Raimundo, Karina
    Antonova, Evgeniya
    Chang, Eunice
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2015, 16 (04) : 313 - 321
  • [25] Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria
    Michael S. Broder
    Karina Raimundo
    Evgeniya Antonova
    Eunice Chang
    American Journal of Clinical Dermatology, 2015, 16 : 313 - 321
  • [26] Long-term tolerability of real-life use of antifibrotic agents (AFA) in Idiopathic Pulmonary Fibrosis (IPF)
    Strens, Danielle
    Bondue, Benjamin
    Dahlqvist, Caroline
    Slabbynck, Hans
    Guiot, Julien
    Joos, Guy
    Gusbin, Natacha
    Wirtz, Gil
    Froidure, Antoine
    Wuyts, Wim
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [27] Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry
    Fan, Yanni
    Bender, Shaun D.
    Conoscenti, Craig S.
    Davidson-Ray, Linda
    Cowper, Patricia A.
    Palmer, Scott M.
    de Andrade, Joao A.
    CHEST, 2020, 157 (06) : 1522 - 1530
  • [28] "The will to live!" The perceptions of patients with idiopathic pulmonary fibrosis (IPF) in relation to antifibrotic treatment: a qualitative study
    Viana Mancuzo, E.
    Neto Generoso, L.
    Mancuzo De Freitas, T.
    Guimaraes Assis, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [29] The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
    Kette, Stefano
    Reccardini, Nicolo
    Salton, Francesco
    Confalonieri, Paola
    Andrisano, Alessia
    Chianese, Maria
    De Nes, Anna
    Maggisano, Marta
    Galantino, Alessandra
    Nicolosi, Salvatore
    Mari, Marco
    Salotti, Andrea
    Angoni, Darina
    Chernovsky, Maria
    Hughes, Michael
    Confalonieri, Marco
    Mondini, Lucrezia
    Ruaro, Barbara
    PHARMACEUTICALS, 2025, 18 (03)
  • [30] Real World Pirfenidone Use Among Patients With Idiopathic Pulmonary Fibrosis: Patient Demographics And Healthcare Resource Utilization Prior To Initiation Of Pirfenidone
    Lalla, D.
    Bengston, L.
    Raimundo, K.
    Korrer, S.
    Liassou, D.
    Elliott, C.
    Limb, S. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345